To view PDF documents
External links included in this website should not be construed as an official endorsement of the views contained therein.
|
What's New
May 2012
April 2012
- Pharmacy Diversion Awareness Conference June 2 & 3, 2012
- Penick Corporation (April 26, 2012)
- Clinical Supplies Management, Inc. (April 26, 2012)
- Catalent Pharma Solutions, Inc. (April 26, 2012)
- Rhodes Technologies (April 26, 2012)
- Almac Clinical Services, Inc., (ACSI) (April 26, 2012)
- Hospira Inc. (April 26, 2012)
- ISP Freetown Fine Chemicals (April 26, 2012)
- Penick
Corporation (April 26, 2012)
- Cambrex
Charles City, Inc. (April 26, 2012)
- Cambrex
Charles City, Inc. (April 26, 2012)
- Rhodes
Technologies (April 26, 2012)
- Cerilliant Corporation (April 26, 2012)
- ISP Freetown Fine Chemicals (April 26, 2012)
- Johnson Matthey Pharma
Services (April 26, 2012)
- Johnson Matthey Inc. (April 26, 2012)
- 2011 Midyear Report PDF (File size 1.79MB)
- Meda Pharmaceuticals Inc. (April 12, 2012)
- Lipomed, Inc. (April 12, 2012)
- Cerilliant Corporation (April 12, 2012)
- Meridian
Medical Technologies (April 2, 2012)
- Mallinckrodt LLC (April 2, 2012)
- Cerilliant Corporation (April 2, 2012)
- Norac Inc. (April 2, 2012)
March 2012
- Daniel B. Brubaker, D.O.; Decision and Order (March 30, 2012)
- Zhiwei Lin, M.D.; Decision and Order (March 28, 2012)
- Morris W. Cochran, M.D.: Revocation of Registration (March 26, 2012)
- Cerilliant Corporation (March 20, 2012)
- Mylan
Technologies Inc. (March 20, 2012)
- Capricorn Pharma Inc. (March 20, 2012)
- Johnson Matthey, Inc., Pharmaceutical Materials (March 20, 2012)
- Cody Laboratories, Inc. (March 20, 2012)
- Cayman Chemical Company (March 20, 2012)
- Johnson Matthey Inc. (March 20, 2012)
- Johnson Matthey Pharmaceutical Materials Inc. (March 20, 2012)
- Noramco Inc. (March 20, 2012)
- Halo Pharmaceutical Inc. (March 20, 2012)
- Controlled Substances and List I Chemical Registration and Reregistration Fees (March 15, 2012)
Supporting and Related Material:
- Bulk Chemical Manufacturer Reports (BCM Online)
- National Center for Natural Products Research-NIDA Project (March 7, 2012)
- Mylan Pharmaceuticals, Inc. (March 1, 2012)
- Mylan Pharmaceuticals,
Inc. (March 1, 2012)
- Proposed Rule: Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids Into Schedule I (March 1, 2012)
February 2012
- Schedules of Controlled Substances: Extension of Temporary
Placement of Five Synthetic Cannabinoids Into Schedule I of the
Controlled Substances Act (February 29, 2012)
- Pharmacy Diversion Awareness Conference (March 17, 2012 & March 18, 2012)
- Information Regarding Carisoprodol Prescriptions
- Noramco, Inc. (February 13, 2012)
- Scott W. Houghton, M.D.; Decision and Order (February 10, 2012)
- Formulation Technologies LLC. (February 6, 2012)
- Cody Laboratories, Inc. (February 6, 2012)
- Cambrex Charles City, Inc. (February 6, 2012)
- Pharmagra
Labs, Inc. (February 6, 2012)
- Siemens
Healthcare Diagnostics Inc. (February 6, 2012)
- PCAS-
Nanosyn, LLC (February 6, 2012)
- Sigma
Aldrich Research Biochemicals, Inc. (February 6, 2012)
- Johnson Matthey Inc. (February 6, 2012)
- Research Triangle Institute (February 6, 2012)
- Cody Laboratories, Inc. (February 6, 2012)
- Johnson Matthey Pharmaceutical
Materials, Inc. (February 6, 2012)
- GE Healthcare (February 6, 2012)
- Cambrex Charles City, Inc. (February 6, 2012)
- Randall L. Wolff, M.D.; Decision and Order (February 1, 2012)
January 2012
- Mallinckrodt, LLC. (January 31, 2012)
- Emilio Luna, M.D.; Decision and Order (January 31, 2012)
- Southwest K-9; Decision and Order (January 31, 2012)
- Mallinckrodt LLC. (January 31, 2012)
- Alltech Associates, Inc. (January 31, 2012)
- Cayman Chemical Company (January 31, 2012)
- Archimica, Inc. (January 31, 2012)
- Technical Amendments and Corrections to DEA Regulations (January 27, 2012)
- Mladen Antolic, M.D.; Decision and Order (January 25, 2012)
- Joseph Deluca, D.O.; Dismissal of Proceeding (January 25, 2012)
- Cerilliant Corporation (January 17, 2012)
- Cerilliant
Corporation (January 17, 2012)
- Siegfried
(USA) (January 17, 2012)
- Cedarburg
Pharmaceuticals, Inc. (January 17, 2012)
- Johnson
Matthey, Inc. (January 17, 2012)
- Austin Pharma LLC. (January 17, 2012)
- AMRI Rensselaer, Inc. (January 17, 2012)
- 30-Day Notice of Information Collection Under Review - Agency Information Collection Activities: Proposed Collection;
Comments Requested: Application for Registration and Application for
Registration Renewal DEA Forms 363 and 363a (January 10, 2012)
- 30-Day Notice of Information Collection Under Review - Agency Information Collection Activities: Proposed Collection;
Comments Requested: Application for Import Quota for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine DEA Form 488 (January 9, 2012)
December 2011
- Mylan Pharmaceuticals, Inc. (December 29, 2011)
- Norac Inc. (December 29, 2011)
- AMPAC Fine Chemicals LLC. (December 29, 2011)
- Chemic Laboratories, Inc. (December 29, 2011)
- 30-Day Notice of Information Collection Under Review - Agency Information Collection Activities; Proposed Collection;
Comments Requested: Application for Registration, Application for
Registration Renewal, Affidavit for Chain Renewal DEA Forms 225, 225a,
225b (December 23, 2011)
- Barry M. Schultz, M.D.; Decision and Order (December 19, 2011)
- Controlled Substances: Established Aggregate Production Quotas for 2012 (December 15, 2011)
- Schedules of Controlled Substances: Placement of Ezogabine Into
Schedule V (December 15, 2011)
- Halo
Pharmaceutical Inc. (December 14, 2011)
- Established Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2012 (December 12, 2011)
- Fisher Clinical Services,
Inc. (December 12, 2011)
- Hospira Inc. (December 12, 2011)
- Johnson Matthey, Inc. (December 12, 2011)
- Research Triangle Institute (December 12, 2011)
- Johnson
Matthey Pharma Services (December 12, 2011)
- Cambridge Isotope Lab (December 12, 2011)
- Chemica (December 12, 2011)
- Lin Zhi International Inc. (December 12, 2011)
- Schedules of Controlled Substances: Placement of Carisoprodol
Into Schedule IV (December 12, 2011)
- Controlled Substances: Final Adjusted Aggregate Production Quotas for 2011 (December 9, 2011)
- Final Adjusted Assessment of Annual Needs for the List I Chemicals: Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2011 (December 9, 2011)
- The Drug Enforcement Administration (DEA) has scheduled another National Prescription Drug Take Back Day which will take place on Saturday, April 28, 2012, from 10:00 a.m. to 2:00 p.m.
- Implementation of the Methamphetamine Production Prevention Act of 2008 (December 1, 2011)
November 2011
- United States Pharmacopeial
Convention (November 29, 2011)
- Noramco Inc. (November 29, 2011)
- Johnson
Matthey, Inc. (November 29, 2011)
- Chemtos, LLC (November 29, 2011)
- Chattem Chemicals Inc. (November 29, 2011)
- Aldrich
Chemical Company Inc. (November 28, 2011)
- Johnson
Matthey Inc. (November 28, 2011)
- Johnson
Matthey Pharmaceutical Materials Inc. (November 28, 2011)
- Mallinckrodt
Inc. (November 28, 2011)
- Alltech Associates Inc. (November 28, 2011)
- Chattem Chemicals Inc. (November 28, 2011)
- Boehringer Ingelheim Chemicals,
Inc. (November 28, 2011)
- Pharmagra Labs Inc. (November 28, 2011)
- Proposed Rule: Classification of Two Steroids, Prostanozol and Methasterone, as
Schedule III Anabolic Steroids Under the Controlled Substances Act (November 23, 2011)
- Kamal Tiwari, M.D.; Pain Management and Surgery Center of
Southern Indiana; Decision and Order (November 18, 2011)
- Robert G. Crummie, M.D.; Decision and Order (November 17, 2011)
- Silviu Ziscovici, M.D.; Decision and Order (November 17, 2011)
- James L. Hooper, M.D.; Decision and Order (November 17, 2011)
- Joseph Giacchino, M.D.; Decision and Order (November 17, 2011)
- Scott D. Fedosky, M.D.; Denial of Application (November 17, 2011)
- NFLIS Estimates Methodology (PDF) (File size 265 KB)
|
|
